Are there preventive measures for individuals with these mutations?
For individuals with confirmed mutations in MLH1, MSH2, MSH6, or PMS2, preventive measures include regular screening and surveillance to detect cancer at an early stage. This may involve annual colonoscopies, endometrial biopsies, and other diagnostic tests. Some individuals may also consider prophylactic surgeries, such as a colectomy or hysterectomy, to reduce their cancer risk.
